Skip to main content
. 2023 Feb 27;2023(2):CD012922. doi: 10.1002/14651858.CD012922.pub2

Sorokina 2022.

Methods Randomised parallel assignment
Participants People with Cheyne‐Stokes respiration and CHF
Interventions Standard medical therapy in combination with acetazolamide 250 mg once daily (n =10) versus standard therapy (n = 11)
Outcomes  

  • AHI

  • Mortality


 
Notes Only abstract available. We contacted the study authors to ask for the full text.

API: apnoea‐hypopnoea index; cAHI: central apnoea‐hypopnoea index; CHF: chronic heart failure; CSA: central sleep apnoea; RCT: randomised controlled trial.